General
Preferred name
succinylcholine
Synonyms
Suxamethonium chloride ()
SUCCINYLCHOLINE CHLORIDE ()
Suxamethonium Chloride Dihydrate ()
choline chloride succinate ()
Succinyldicholine dichloride ()
Succinylcholine Chloride Dihydrate ()
SUXAMETHONIUM ()
SUXAMETHONIUM BROMIDE ()
Suxamethonium cation ()
Succinylcholine ()
Succinylcholine ion ()
Suxamethonium ion ()
Sucostrin ()
Succinylcholine cation ()
Anectine ()
Quelicin ()
Choline chloride succinate (2:1) ()
NSC-49132 ()
Suxamethonii chloridum ()
Suxamethonium chloride dihydrate ()
Scoline ()
Suxamethonium Chloride ()
Suxamethonium chloride hydrate ()
Quelicin Preservative Free ()
Suxamethone ()
Succinylcholine bromide ()
NSC-151059 ()
Succinylcholine (chloride hydrate) ()
P&D ID
PD010173
CAS
6101-15-1
306-40-1
10168-63-5
71-27-2
Tags
available
drug candidate
drug
Approved by
FDA
First approval
1952
Drug Status
approved
Drug indication
Spasm
Neuromuscular Blocking Agent
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Succinylcholine (sux) is a short-acting depolarizing neuromuscular blocker. It acts as an acetylcholine agonist at nicotinic acetylcholine receptors at neuromuscular junctions, resulting in persistent depolarization of the motor end plate.
(GtoPdb)
DESCRIPTION
Nicotinic acetylcholine receptor antagonist.
(LOPAC library)
DESCRIPTION
Succinylcholine Chloride Dihydrate is a nicotinic AChR agonist and also acts as a depolarizing neuromuscular blocker.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
25
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
Ki Database
LOPAC library
NCATS Inxight Approved Drugs
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
76
Properties
(calculated by RDKit )
Molecular Weight
290.22
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
0
Rotatable Bonds
9
Ring Count
0
Aromatic Ring Count
0
cLogP
0.27
TPSA
52.6
Fraction CSP3
0.86
Chiral centers
0.0
Largest ring
0.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
Nicotinic
MOA
nicotinic acetylcholine receptor antagonist
AChR agonist
Target
Muscle-type nicotinic acetylcholine receptor
Nicotinic AChR
CHRFAM7A, CHRM1, CHRM2, CHRM3, CHRNA1, CHRNA10
AChR
Pathway
Neuroscience
Indication
muscle relaxant
Therapeutic Class
Analgesics
Solubility
Soluble in DMSO (Slightly, Sonicated), Methanol (Slightly), Water (Slightly)
Source data